Strados Labs developed the Remote E-Stethoscope Platform (RESP), the world first clinical-grade wearable e-stethoscope. RESP™ offers clinicians a cost-effective, non-invasive and wireless solution that enables remote detection of key changes in lung acoustics and ventilation patterns of patients between nursing rounds and health visits. We aim to help clinicians identify pulmonary complications and respiratory distress earlier to avoid costly and life-threatening hospitalizations. Strados Labs plans to submit the RESP product for FDA 510(k) clearance in the winter of 2019, and has run several successful clinical trials with the platform across the U.S.